microHeart wins Edison Award Gold in the Medical/Dental Cellular Research category.
April 18, 2018 –The world’s most talented innovation leaders were honored on April 11 for their tireless contributions in launching new products that will change the world in the fields of Science and Medical, Robotics, Energy and Sustainability, Commercial Safety and the future of Space Travel. One of the evening highlights included Marillyn Hewson, Chairman, President and CEO of Lockheed Martin Corporation accepting the Edison Awards’ highest honor, the Edison Achievement Award, for her leadership and significant contribution to innovation throughout her career while doubling the market cap of Lockheed Martin since she started as CEO in 2013.
StemoniX® is transforming how medicine is discovered. By using skin or blood to create functioning microHearts® and microBrains®, StemoniX is making it possible to test medication on humans without that medication ever entering their bodies. This method of drug testing will speed up the search for new cures and enable the ability to test drug effectiveness on an individual person, so medicine works correctly the first time. For more information visit www.stemonix.com.
Interested in getting in touch? Send us an email firstname.lastname@example.org and we will be happy to get back to you.